(Updated - April 4, 2023 7:47 AM EDT)

Jefferies analyst Dennis Ding downgraded Pardes Biosciences (NASDAQ: PRDS) from Buy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE